@misc{indiciae8aec4e59ac78,
  title = {Breast cancer mutations HER2 V777L and PIK3CA H1047R activate the p21/CDK4/6/Cyclin D1 axis driving tumorigenesis and drug resistance.},
  author = {Cheng, X. and Sun, Y. and Highkin, M. and Vemalapally, N. and Jin, X. and Zhou, B. and Prior, J. L. and Tipton, A. R. and Li, S. and Iliuk, A. and Achilefu, S. and Hagemann, I. S. and Edwards, J. R. and Bose, R.},
  year = {2022},
  doi = {10.1101/2022.11.09.515796},
  url = {https://www.biorxiv.org/content/10.1101/2022.11.09.515796v1},
  note = {Source identifier: 10.1101/2022.11.09.515796}
}